# BioSeek

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/bioseek

- Industry: Pharmaceuticals
- Headquarters: San Francisco, US
- Website: www.bioseekinc.com
- Total disclosed funding: $14M
- Latest round: Series B (Jul 1, 2004)
- Investors on record: 4

## About

BioSeek, Inc. specializes in drug development services, leveraging innovative technologies to enhance therapeutic discovery and inform drug development strategies for biotechnology and pharmaceutical clients.Founded in 2000, BioSeek, Inc. is located in San Francisco, US, and focuses on supporting drug development through advanced biological testing services. The company has completed 5 deals since its inception, with the most recent deal being a TRADE SALE to Asterand in November 2009 for USD 14.00 mn, which represents the total amount raised by the company.BioSeek offers a range of drug development services that utilize unique biological models and assays designed to support therapeutic discovery. Their capabilities enable clients to gain insights into drug efficacy and safety, catering to the needs of biotechnology and pharmaceutical sectors. BioSeek's services are essential for clients aiming to advance their products through various stages of development while ensuring compliance with industry standards.BioSeek generates revenue through tailored B2B service agreements and partnerships with clients. Their structured transaction model involves providing specialized testing services, enabling flexibility in service delivery. Clients typically engage BioSeek through contracts that address specific needs, ensuring a continuous revenue stream from ongoing testing and support services that align with regulatory requirements and quality assurance.Following its acquisition by Asterand in November 2009, BioSeek plans to leverage the resources from this transaction to enhance its product offerings and expand into new geographic markets. The company is currently strategizing the launch of new biological testing services aimed at biotechnology firms, with a targeted rollout expected in the next 12 to 18 months. Additionally, BioSeek plans to explore expansion opportunities in the European and Asian markets to increase its global footprint and service capabilities.

## Funding rounds

- Series B, Jul 1, 2004, $5.6M — Vanguard Ventures, Fremont Private Holdings, Bay City Capital, SImile Investors
- Series A, Feb 20, 2002, $8.4M — Vanguard Ventures, Fremont Private Holdings, Bay City Capital, SImile Investors

## Investors

- Vanguard Ventures (https://capitalatlas.ai/funds/vanguard-ventures) — Series A, Series B
- Fremont Private Holdings (https://capitalatlas.ai/funds/fremont-private-holdings) — Series A, Series B
- Bay City Capital (https://capitalatlas.ai/funds/bay-city-capital) — Series A, Series B
- SImile Investors — Series A, Series B